Amrutanjan Health Care Limited (AMRUTANJAN) - Net Assets
Based on the latest financial reports, Amrutanjan Health Care Limited (AMRUTANJAN) has net assets worth Rs3.42 Billion INR (≈ $36.99 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs4.32 Billion ≈ $46.76 Million USD) and total liabilities (Rs902.90 Million ≈ $9.76 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of Amrutanjan Health Care Limited to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs3.42 Billion |
| % of Total Assets | 79.12% |
| Annual Growth Rate | 16.35% |
| 5-Year Change | 51.52% |
| 10-Year Change | 200.36% |
| Growth Volatility | 56.52 |
Amrutanjan Health Care Limited - Net Assets Trend (2006–2025)
This chart illustrates how Amrutanjan Health Care Limited's net assets have evolved over time, based on quarterly financial data. Also explore AMRUTANJAN total asset value for the complete picture of this company's asset base.
Annual Net Assets for Amrutanjan Health Care Limited (2006–2025)
The table below shows the annual net assets of Amrutanjan Health Care Limited from 2006 to 2025. For live valuation and market cap data, see AMRUTANJAN company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | Rs3.27 Billion ≈ $35.32 Million |
+13.22% |
| 2024-03-31 | Rs2.88 Billion ≈ $31.20 Million |
-0.79% |
| 2023-03-31 | Rs2.91 Billion ≈ $31.45 Million |
+9.67% |
| 2022-03-31 | Rs2.65 Billion ≈ $28.67 Million |
+22.99% |
| 2021-03-31 | Rs2.16 Billion ≈ $23.31 Million |
+35.21% |
| 2020-03-31 | Rs1.59 Billion ≈ $17.24 Million |
+9.39% |
| 2019-03-31 | Rs1.46 Billion ≈ $15.76 Million |
+13.27% |
| 2018-03-31 | Rs1.29 Billion ≈ $13.91 Million |
+1.72% |
| 2017-03-31 | Rs1.26 Billion ≈ $13.68 Million |
+16.32% |
| 2016-03-31 | Rs1.09 Billion ≈ $11.76 Million |
+14.52% |
| 2015-03-31 | Rs949.51 Million ≈ $10.27 Million |
+6.40% |
| 2014-03-31 | Rs892.39 Million ≈ $9.65 Million |
+8.47% |
| 2013-03-31 | Rs822.67 Million ≈ $8.90 Million |
-14.72% |
| 2012-03-31 | Rs964.67 Million ≈ $10.43 Million |
-4.86% |
| 2011-03-31 | Rs1.01 Billion ≈ $10.96 Million |
+5.01% |
| 2010-03-31 | Rs965.51 Million ≈ $10.44 Million |
+3.48% |
| 2009-03-31 | Rs933.00 Million ≈ $10.09 Million |
+258.20% |
| 2008-03-31 | Rs260.47 Million ≈ $2.82 Million |
+11.25% |
| 2007-03-31 | Rs234.13 Million ≈ $2.53 Million |
+27.40% |
| 2006-03-31 | Rs183.78 Million ≈ $1.99 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Amrutanjan Health Care Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 272956600000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rs2.73 Billion | 83.57% |
| Common Stock | Rs28.91 Million | 0.89% |
| Other Comprehensive Income | Rs518.27 Million | 15.87% |
| Total Equity | Rs3.27 Billion | 100.00% |
Amrutanjan Health Care Limited Competitors by Market Cap
The table below lists competitors of Amrutanjan Health Care Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
TIDEWATER RENEWABLES LTD
F:7GZ
|
$178.57 Million |
|
Wei Chih Steel Industrial Co Ltd
TW:2028
|
$178.65 Million |
|
FineTek Co Ltd
TWO:4549
|
$178.69 Million |
|
NOVAREX Co.Ltd
KQ:194700
|
$178.75 Million |
|
Falcon Oil & Gas Ltd
F:FAC
|
$178.51 Million |
|
Sierra Metals Inc.
TO:SMT
|
$178.24 Million |
|
Ensari Deri Gida Sanayi ve Ticaret AS
IS:ENSRI
|
$178.24 Million |
|
PULSION Medical Systems SE
MU:PUS
|
$178.09 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Amrutanjan Health Care Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,884,883,000 to 3,266,146,000, a change of 381,263,000 (13.2%).
- Net income of 508,347,000 contributed positively to equity growth.
- Dividend payments of 132,665,000 reduced retained earnings.
- Share repurchases of 2,378,000 reduced equity.
- New share issuances of 2,378,000 increased equity.
- Other comprehensive income increased equity by 8,258,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs508.35 Million | +15.56% |
| Dividends Paid | Rs132.66 Million | -4.06% |
| Share Repurchases | Rs2.38 Million | -0.07% |
| Share Issuances | Rs2.38 Million | +0.07% |
| Other Comprehensive Income | Rs8.26 Million | +0.25% |
| Other Changes | Rs-2.68 Million | -0.08% |
| Total Change | Rs- | 13.22% |
Book Value vs Market Value Analysis
This analysis compares Amrutanjan Health Care Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.06x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 99.46x to 5.06x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-03-31 | Rs5.74 | Rs571.20 | x |
| 2007-03-31 | Rs7.32 | Rs571.20 | x |
| 2008-03-31 | Rs8.14 | Rs571.20 | x |
| 2009-03-31 | Rs29.34 | Rs571.20 | x |
| 2010-03-31 | Rs31.80 | Rs571.20 | x |
| 2011-03-31 | Rs33.46 | Rs571.20 | x |
| 2012-03-31 | Rs33.00 | Rs571.20 | x |
| 2013-03-31 | Rs28.14 | Rs571.20 | x |
| 2014-03-31 | Rs30.53 | Rs571.20 | x |
| 2015-03-31 | Rs32.48 | Rs571.20 | x |
| 2016-03-31 | Rs37.20 | Rs571.20 | x |
| 2017-03-31 | Rs43.27 | Rs571.20 | x |
| 2018-03-31 | Rs44.01 | Rs571.20 | x |
| 2019-03-31 | Rs49.86 | Rs571.20 | x |
| 2020-03-31 | Rs54.54 | Rs571.20 | x |
| 2021-03-31 | Rs73.73 | Rs571.20 | x |
| 2022-03-31 | Rs90.68 | Rs571.20 | x |
| 2023-03-31 | Rs99.49 | Rs571.20 | x |
| 2024-03-31 | Rs98.87 | Rs571.20 | x |
| 2025-03-31 | Rs112.95 | Rs571.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Amrutanjan Health Care Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 15.56%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.28%
- • Asset Turnover: 1.07x
- • Equity Multiplier: 1.29x
- Recent ROE (15.56%) is below the historical average (21.62%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | 32.19% | 8.95% | 1.79x | 2.01x | Rs40.79 Million |
| 2007 | 25.26% | 8.17% | 1.75x | 1.77x | Rs35.72 Million |
| 2008 | 19.31% | 6.74% | 1.55x | 1.85x | Rs24.23 Million |
| 2009 | 99.03% | 101.91% | 0.82x | 1.19x | Rs830.64 Million |
| 2010 | 11.88% | 12.78% | 0.76x | 1.23x | Rs18.17 Million |
| 2011 | 10.07% | 9.69% | 0.67x | 1.55x | Rs729.76K |
| 2012 | 9.99% | 6.73% | 1.00x | 1.49x | Rs-116.52K |
| 2013 | 12.30% | 7.40% | 1.10x | 1.51x | Rs18.90 Million |
| 2014 | 13.94% | 8.78% | 1.18x | 1.35x | Rs35.20 Million |
| 2015 | 15.88% | 9.05% | 1.34x | 1.30x | Rs55.79 Million |
| 2016 | 18.92% | 11.02% | 1.33x | 1.29x | Rs97.01 Million |
| 2017 | 16.93% | 9.64% | 1.36x | 1.29x | Rs87.61 Million |
| 2018 | 15.52% | 9.00% | 1.34x | 1.29x | Rs71.07 Million |
| 2019 | 16.82% | 9.73% | 1.34x | 1.29x | Rs99.41 Million |
| 2020 | 15.73% | 9.62% | 1.27x | 1.29x | Rs91.41 Million |
| 2021 | 28.39% | 18.46% | 1.21x | 1.27x | Rs396.34 Million |
| 2022 | 25.34% | 16.57% | 1.16x | 1.32x | Rs406.77 Million |
| 2023 | 13.70% | 10.50% | 1.05x | 1.25x | Rs107.58 Million |
| 2024 | 15.59% | 10.68% | 1.15x | 1.27x | Rs161.24 Million |
| 2025 | 15.56% | 11.28% | 1.07x | 1.29x | Rs181.73 Million |
Industry Comparison
This section compares Amrutanjan Health Care Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $26,186,185,291
- Average return on equity (ROE) among peers: 7.92%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Amrutanjan Health Care Limited (AMRUTANJAN) | Rs3.42 Billion | 32.19% | 0.26x | $178.52 Million |
| Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) | $988.60 Million | 6.59% | 1.36x | $27.93 Million |
| Aarti Drugs Limited (AARTIDRUGS) | $6.52 Billion | 21.67% | 1.42x | $371.43 Million |
| Aarti Pharmalabs Limited (AARTIPHARM) | $19.90 Billion | 13.69% | 0.46x | $725.68 Million |
| Abbott India Limited (ABBOTINDIA) | $36.99 Billion | 32.48% | 0.40x | $5.85 Billion |
| Ajanta Pharma Limited (AJANTPHARM) | $1.16 Billion | 12.69% | 1.32x | $3.81 Billion |
| Akums Drugs and Pharmaceutical (AKUMS) | $6.25 Billion | -40.39% | 3.91x | $906.19 Million |
| Alkem Laboratories Limited (ALKEM) | $88.47 Billion | 18.60% | 0.59x | $6.98 Billion |
| Alembic Pharmaceuticals Limited (APLLTD) | $51.90 Billion | 11.24% | 0.50x | $1.60 Billion |
| Aurobindo Pharma Limited (AUROPHARMA) | $23.50 Billion | -5.26% | 1.65x | $8.73 Billion |
About Amrutanjan Health Care Limited
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products in India and internationally. It operates through OTC Products, Beverages, Women's Hygiene, and Others segments. The company provides pain management products comprising pain balms and roll-ons, back pain roll-ons, stick-on patch, and joint muscle sprays; dental pain gel; and decorn co… Read more